Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487253
Status:
UNKNOWN
Last Update Posted:
2010-02-17
First Post:
2007-06-14
Brief Title:
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
Sponsor:
Centro Internacional de Entrenamiento e Investigaciones Médicas
Organization:
Centro Internacional de Entrenamiento e Investigaciones Médicas
Study Overview
Official Title:
Randomized Clinical Trial of the Efficacy and Tolerability of Oral Miltefosine Versus Parenteral Antimony for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
Status:
UNKNOWN
Status Verified Date:
2010-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this randomized open label clinical trial is to determine if oral miltefosine is a safe and effective alternative compared with parenteral meglumine antimoniate for the treatment of pediatric Cutaneous caused by L Viannia species in Colombia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None